Ben Tre Pharmaceutical JSC (VN:DBT) — Market Cap & Net Worth
Market Cap & Net Worth: Ben Tre Pharmaceutical JSC (DBT)
Ben Tre Pharmaceutical JSC (VN:DBT) has a market capitalization of $10.43 Million (₫274.59 Billion) as of May 22, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #26919 globally and #184 in its home market, demonstrating a 5.93% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ben Tre Pharmaceutical JSC's stock price ₫12500.00 by its total outstanding shares 21967262 (21.97 Million).
Ben Tre Pharmaceutical JSC Market Cap History: 2015 to 2026
Ben Tre Pharmaceutical JSC's market capitalization history from 2015 to 2026. Data shows change from $627.79 Million to $10.43 Million (-31.07% CAGR).
Ben Tre Pharmaceutical JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ben Tre Pharmaceutical JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DBT by Market Capitalization
Companies near Ben Tre Pharmaceutical JSC in the global market cap rankings as of May 22, 2026.
Key companies related to Ben Tre Pharmaceutical JSC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #500 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #550 globally with a market cap of $48.03 Billion USD ( CN¥328.20 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #554 globally with a market cap of $47.66 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #612 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #500 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #550 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $48.03 Billion | CN¥51.45 |
| #554 | GALDERMA GROUP AG | NYSE:GALDY | $47.66 Billion | $40.64 |
| #612 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.00 |
Ben Tre Pharmaceutical JSC Historical Marketcap From 2015 to 2026
Between 2015 and today, Ben Tre Pharmaceutical JSC's market cap moved from $627.79 Million to $ 10.43 Million, with a yearly change of -31.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫10.43 Million | +11.11% |
| 2025 | ₫9.39 Million | -7.79% |
| 2024 | ₫10.18 Million | -85.99% |
| 2023 | ₫72.68 Million | -74.04% |
| 2022 | ₫279.96 Million | -29.25% |
| 2021 | ₫395.70 Million | -46.00% |
| 2020 | ₫732.77 Million | +14.29% |
| 2019 | ₫641.17 Million | +7.54% |
| 2018 | ₫596.22 Million | -19.53% |
| 2017 | ₫740.97 Million | +7.37% |
| 2016 | ₫690.13 Million | +9.93% |
| 2015 | ₫627.79 Million | -- |
End of Day Market Cap According to Different Sources
On May 22nd, 2026 the market cap of Ben Tre Pharmaceutical JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.43 Million USD |
| MoneyControl | $10.43 Million USD |
| MarketWatch | $10.43 Million USD |
| marketcap.company | $10.43 Million USD |
| Reuters | $10.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ben Tre Pharmaceutical JSC
Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascul… Read more